騰景科技(688195.SH):目前在手訂單較為充裕
格隆匯7月19日丨騰景科技(688195.SH)披露投資者關係活動記錄表顯示,公司目前在手訂單較為充裕,積極滿足客户產品交付,生產經營情況良好。
在光通信方面,隨着光通信技術不斷升級,5G、大數據、雲計算、人工智能等數字經濟應用的融合發展和產業數字化進程的不斷推進,海量數據差異化傳輸需求持續增長,作為信息通信網絡的基礎承載底座,光通信元器件市場迎來了廣闊的發展空間。隨着行業下游去庫存影響逐步結束,光通信整體市場回暖。公司不斷豐富和完善光通信領域的技術和產品,滿足下游客户對於更長傳輸距離、更大帶寬容量的升級需求。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.